Elobix AB
Records under this name other than the patents Elobix AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 4 of 4 · Back to Elobix AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,183,920 | Crystal Modifications of Elobixibat Formerly held In force · High confidence | In force | High confidence | |
| US 7,192,945 | Benzothiazepine Derivatives Term ended Ended no later than Dec 21, 2022 · Medium confidence | Term ended | Ended no later than Dec 21, 2022 | Medium confidence |
| US 7,192,946 | Benzothiazepine Derivatives Lapsed on the fee record Ended Mar 20, 2019 · Medium confidence | Lapsed on the fee record | Ended Mar 20, 2019 | Medium confidence |
| US 7,192,947 | Peptides Derivatives Comprising Thiazepine Group for the Treatment of Hyperlipidermic Conditions Lapsed on the fee record Ended Mar 20, 2019 · Medium confidence | Lapsed on the fee record | Ended Mar 20, 2019 | Medium confidence |